ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 65921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 65921; 2) Community: the network communities that were significantly associated with the response to NSC 65921; 3) Molecule: the relationships between components within communities and NSC 65921; 4) MDR: the compounds that were significantly associated with the NSC 65921.

NSC Compound Enrichment Correlation
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0385067071027343 0.24960314
NSC 79304 Null 0.0385067071027343 0.30995048
NSC 688303 Null 0.0386895225700407 -0.13085963
NSC 691216 Null 0.0386895225700407 -0.064989229
NSC 693167 Null 0.0386895225700407 0.0095484314
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0386895225700407 0.041820312
NSC 700447 Null 0.0386895225700407 -0.13532972
NSC 700584 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-diselone, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0386895225700407 0.1062165
NSC 704080 Null 0.0386895225700407 -0.079492296
NSC 709237 Camptothecin Derivative 0.0386895225700407 0.17766676
Total:93  Current:57    [First] [Prev] [Next] [Last]